Key result
Transcatheter closure of outlet-type ventricular septal defects with the Amplatzer Duct Occluder II was successful in 91.8% of patients, with no heart block or device failure during follow-up.
Why the study?
Outlet-type VSD frequently requires surgery due to aortic valve prolapse, and literature evaluating the outcomes of transcatheter closure is scant.
Does transcatheter closure with Amplatzer Duct Occluder II safely and effectively treat outlet-type ventricular septal defects in children and adults?
Observational (n=49)
Does transcatheter closure with Amplatzer Duct Occluder II safely and effectively treat outlet-type ventricular septal defects in children and adults?
Transcatheter closure of outlet-type VSDs using the Amplatzer Duct Occluder II is feasible and safe in the short-to-mid-term, with a high success rate and no occurrence of heart block.
Supports transcatheter outlet VSD closure in select patients; leaves open need for RCTs on long-term safety and efficacy.
BACKGROUND/PURPOSE: Outlet-type VSD is frequently associated with aortic valve prolapse that surgery is frequently required. The literature regarding outcomes of transcatheter closure of outlet-type VSDs is scant. This study was conducted to know the safety and efficacy of transcatheter closure of outlet-type ventricular septal defects (VSDs) with Amplatzer Duct Occluder II (ADO II). METHODS: Medical records of patients underwent attempted transcatheter closure of outlet-type VSD with ADO II between October 2013 and August 2019 were retrospectively reviewed. RESULTS: Among 49 patients, transcatheter closure was successful in 45 (91.8%; 33 males and 12 females; mean [± standard deviation] age and body weight: 15.8 (±17.7) years and 36.6 (±23.3) kg, respectively). The median VSD diameter was 4.0 mm (range: 1.2-6.0 mm). Device closure failed in four because the sheath could not be advanced through a prograde or retrograde route in one patient, occluder embolization in the two patients, and failed right ventricular disc anchoring in one patient. After a mean follow-up of 22.7 months (range: 0.3-51.1 months), only nine (20.0%) patients had increased severity in aortic regurgitation (AR) on the echocardiography. Preprocedural AR decreased in severity or even disappeared in 11 (24.4%) patients. No heart block or device failure occurred during follow-up. A trivial-to-small residual shunt was detected in 19 patients (42.2%) in the most recent echocardiography. CONCLUSION: Transcatheter closure of outlet-type VSDs with ADO II is feasible. Although no significant aggravation of AR was observed in the short-to-mid-term follow-up, long-term follow-up is mandatory.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2020) conducted an observational in Outlet-type ventricular septal defects (VSDs) (n=49). Transcatheter closure with Amplatzer Duct Occluder II (ADO II) was evaluated on Successful transcatheter closure. Transcatheter closure of outlet-type ventricular septal defects with the Amplatzer Duct Occluder II was successful in 91.8% of patients, with no heart block or device failure during follow-up.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: